Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (A60217) - R2 - Effective October 1, 2026

Date Posted: October 29, 2026

This Billing and Coding Article has been revised under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Effective Date: October 1, 2026

Summary of Changes:

Under CPT/HCPCS Codes Group 1: Codes added 0665U. This revision is due to the 2026 Q4 CPT/HCPCS Code Update and is effective 10/1/2026.

Under CPT/HCPCS Group 1: Paragraph added "The codes listed below fall within scope of the associated policy but do not automatically imply coverage". This revision is effective 10/1/2026.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated Oct 29 , 2026